deltatrials

Obsessive-compulsive disorder Trials in Los Angeles, United States

Conditions / Obsessive-compulsive disorder / Los Angeles, United States

Research into Obsessive-compulsive disorder spans multiple therapeutic approaches and trial phases.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID Title Status Phase
NCT01687140 The Use of D-Cycloserine to Augment CBT for Pediatric OCD UNKNOWN PHASE2
NCT00674219 Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder COMPLETED PHASE3
NCT04641143 Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder COMPLETED PHASE3
NCT04693351 Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder COMPLETED PHASE3
NCT02229903 An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD COMPLETED NA
NCT01275248 Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder TERMINATED PHASE2
NCT04708834 Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder TERMINATED PHASE3
NCT01302080 Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES) COMPLETED
NCT00748761 Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder COMPLETED NA
NCT03299166 Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder COMPLETED PHASE2/PHASE3

Related Pages